Sinupret

phytopharmaceutic composed of Gentiana lutea, root; Primula veris, flower; Rumex sp., herb; Sambucus nigra, flower; Verbena officinalis, herb); available in solution or tablet form; used in treatment of chronic sinusitis

Networked: 28 relevant articles (4 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Gotsadze, K: 2 articles (10/2007 - 04/2005)
2.	Bykov, I A: 1 article (01/2022)
3.	Kokorina, V E: 1 article (01/2022)
4.	Ditrikh, O A: 1 article (01/2021)
5.	Sen'kevich, O A: 1 article (01/2021)
6.	Sidorenko, S V: 1 article (01/2021)
7.	Abramov-Sommariva, D: 1 article (06/2017)
8.	Ammendola, A: 1 article (06/2017)
9.	Bachert, C: 1 article (06/2017)
10.	Mitzenheim, S: 1 article (06/2017)

Related Diseases

1.	Sinusitis 04/01/2006 - "Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis." 05/01/2005 - "The herbal medicinal product Sinupret has been successfully used for the treatment of sinusitis for 70 years. " 01/01/2001 - "[The administration of sinupret in the treatment of acute sinusitis in children]." 09/01/1980 - "[Treatment of chronic sinusitis with Sinupret]." 12/01/1994 - "Conventional therapy for acute bacterial sinusitis can be improved markedly by including Sinupret in the therapeutic regimen."
2.	Rhinosinusitis 09/01/2013 - "Sinupret drug has been proven effective in clinical trials, as a drug for both acute and chronic rhinosinusitis, in children and adults. " 01/01/2015 - "A prospective open-label study to assess the efficacy and safety of a herbal medicinal product (Sinupret) in patients with acute rhinosinusitis." 01/01/2023 - "A comparative study of the efficacy and safety of clinical use in patients of the drug Sinupret extract in patients with acute viral rhinosinusitis was carried out in comparison with symptomatic treatment. " 01/01/2023 - "To evaluate the efficacy and safety of using the drug Sinupret extract in patients with acute viral rhinosinusitis. " 01/01/2023 - "The issues of epidemiology, etiopathogenesis, diagnostics and clinic of acute catarrhal rhinosinusitis are considered, the possibility of using the herbal medicinal product Sinupret extract in the treatment of patients with acute viral rhinosinusitis is substantiated. "
3.	Infections 10/20/1972 - "[Prevention of infection in the bronchitic syndrome by Sinupret]." 11/06/1975 - "Sinupret is especially suitable for treatment after the acute phase of sinusitis during intervalls and as prophylaxis during the cold months with frequent infections of the upper respiratory tract." 09/01/2001 - "Enhanced resistance to Sendai virus infection in DBA/2J mice with a botanical drug combination (Sinupret)." 01/01/1999 - "In the case of Sinupret, a combination of 5 botanical drugs, the pharmacological profile was investigated thoroughly with respect to activities on secretion of the respiratory epithelium, with respect to anti-inflammatory activities and to effects against a murine Sendai-virus infection model (including in-vitro antiviral activities), after a randomised, placebo-controlled study of the ENT-clinic of the University of Freiburg had shown superiority of the verum in patients with chronic sinusitis. " 12/15/2011 - "Therefore experiments have been performed to measure the antiviral activity of Sinupret(®) oral drops (hereinafter referred to as "oral drops") and Sinupret(®) dry extract (hereinafter referred to as "dry extract"), in vitro against a broad panel of both enveloped and non-enveloped human pathogenic RNA and DNA viruses known to cause infections of the upper respiratory tract: influenza A, Chile 1/83 (H1N1) virus (FluA), Porcine Influenza A/California/07/2009 (H1N1) virus (pFluA), parainfluenza type 3 virus (Para 3), respiratory syncytial virus, strain Long (RSV), human rhinovirus B subtype 14 (HRV 14), coxsackievirus subtype A9 (CA9), and adenovirus C subtype 5 (Adeno 5). "
4.	COVID-19 01/01/2022 - "We analyzed influence of the drug Sinupret on the restoration dynamic of the olfactory dysfunction associated with SARS-CoV-2 infection. " 01/01/2022 - "187 patients with impaired sense of smell associated with SARS-CoV-2 infection were included in this study: test group consisted of 104 cases in which olfactory training methods were combined with the prescription of the drug Sinupret. "
5.	Otitis Media 01/01/2009 - "[The use of sinupret in the combined treatment of acute otitis media in children]." 10/01/2007 - "Systemic inflammatory responses in patients with acute otitis media and the impact of treatment with sinupret." 04/01/2007 - "To treat seros otitis media Sinupret was used as a monotherapy drug. " 10/01/2007 - "The systemic inflammatory responses and the impact of sinupret therapy have been investigated in 14 patients with acute otitis media, AOM. " 04/01/2007 - "In treatment of acute otitis media and sinusitis Sinupret is recommended in the third period of disease in combination with antibiotics."

Related Drugs and Biologics

1.	Anti-Bacterial Agents (Antibiotics)
2.	Nasal Decongestants (Decongestants)
3.	gentian root extract
4.	Saccharin
5.	Antiviral Agents (Antivirals)
6.	Drug Combinations
7.	Nasal Sprays
8.	RNA (Ribonucleic Acid)
9.	Chlorides
10.	Bromelains (Bromelain)

Related Therapies and Procedures

1.	Therapeutics
2.	Olfactory Training
3.	Physical Therapy Modalities (Physical Therapy Technique)
4.	Drug Therapy (Chemotherapy)